This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has an award value of $22,687.47 and a completion date of December 5, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.
Generated 3/9/25, 12:48 AM